1
|
Moran T, Sequist LV. Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer WithEGFRMutations. J Clin Oncol 2012; 30:3330-6. [DOI: 10.1200/jco.2012.43.1858] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Affiliation(s)
- Teresa Moran
- Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Universitat Autonoma de Barcelona, Barcelona, Spain; Massachusetts General Hospital, Boston, MA
| | - Lecia V. Sequist
- Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA
| |
Collapse
|